The federal government will only have a limited regulatory say if British miner Rio Tinto PLC RTPPF ends up buying Glencore ...
MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
With outrage building, Mr. Musk has changed his tune somewhat, at least publicly, although he appears to blame users, rather ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback